MSD explores applying generative Al to improve the deviation management process using AWS services
This post is co-written with Hossein Salami and Jwalant Vyas from MSD. In the biopharmaceutical industry, deviations in the manufacturing process are rigorously addressed. Each deviation is thoroughly documented, and its various aspects and potential impacts are closely examined to help ensure drug product quality, patient safety, and compliance. For leading pharmaceutical companies, managing these…


